468 Capital — 2024 Investments
2 investments dated 2024 · listed companies and verified rows first · show all
Codespherecodesphere.comin𝕏May 2024
Karlsruhe
Elias Schneider(Executive Officer, Director)Jonas Zipprick(Executive Officer, Director)Carl Fritjofsson(Director)
Exin Therapeuticsexintherapeutics.comin𝕏Nov 2024
Exin Therapeutics develops an AI-guided drug discovery platform that uses experimental mouse studies to identify neurological therapies, starting with epilepsies linked to autism and Parkinson's disease.
BiotechHealthtechSan Francisco, US
Gabriel Ocana Santero(Founder)inMarko Tvrdic(Founder)inIvan Alex Priela Lazarte(Executive Officer, Director)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.